Journey Medical Corp Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Journey Medical Corp (DERM) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $1.94 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-08-12
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.94M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.91M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.06M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.13M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $1.94M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $2.91M 10-Q · filed 2026-05-13 |
| 2025-09-30 | $1.06M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.13M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $3.19M 10-Q · filed 2025-05-15 |
| 2024-09-30 | $814.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.63M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $2.44M 10-Q · filed 2024-05-14 |
| 2023-09-30 | $813.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.63M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.21M 10-Q · filed 2023-05-22 |
| 2022-09-30 | $1.02M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.03M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.05M 10-Q · filed 2022-05-10 |
| 2021-09-30 | $491.00K 10-Q · filed 2021-12-16 |